Detalhe da pesquisa
1.
Obinutuzumab versus Rituximab in transplant-eligible Mantle cell lymphoma patients.
Blood
; 2024 04 26.
Artigo
Inglês
| MEDLINE | ID: mdl-38669626
2.
Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases.
Br J Haematol
; 189(2): 244-256, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32030731
3.
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center.
Am J Hematol
; 95(11): 1324-1333, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32744738
4.
Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes.
Hematol Oncol
; 2018 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29722049
5.
SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphoma.
Ann Hematol
; 97(1): 123-131, 2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-28993857
6.
Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study.
J Clin Oncol
; 42(7): 769-773, 2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38109684
7.
Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial.
Sci Rep
; 13(1): 18177, 2023 10 24.
Artigo
Inglês
| MEDLINE | ID: mdl-37875524
8.
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma.
Blood Adv
; 7(5): 744-755, 2023 03 14.
Artigo
Inglês
| MEDLINE | ID: mdl-35439292
9.
Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data.
Blood Adv
; 6(2): 533-543, 2022 01 25.
Artigo
Inglês
| MEDLINE | ID: mdl-34749395
10.
Rituximab in combination with adapted-dose of ifosfamide and etoposide as salvage treatment in elderly refractory/relapsed diffuse large B-cell lymphoma patients non-candidate for high dose therapy: a retrospective study.
Leuk Lymphoma
; 63(3): 599-607, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34720034
11.
Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified.
Blood Adv
; 5(16): 3227-3239, 2021 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-34427583
12.
Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma.
Blood Adv
; 5(2): 539-548, 2021 01 26.
Artigo
Inglês
| MEDLINE | ID: mdl-33496747
13.
Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells.
Clin Nucl Med
; 46(8): 627-634, 2021 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34115706
14.
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group.
Lancet Haematol
; 7(11): e798-e807, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32971036
15.
L'émergence des traitements par cellules CAR-T dans les lymphomes.
Bull Cancer
; 105 Suppl 2: S168-S177, 2018 Dec.
Artigo
Francês
| MEDLINE | ID: mdl-30686355
16.
Flare-up phenomenon or pseudoprogression after CAR T-cell infusion in non-Hodgkin aggressive lymphomas.
Leuk Lymphoma
; 64(3): 707-711, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36573418
17.
Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor T cell immunotherapy recipients.
Cancer Cell
; 40(3): 236-237, 2022 03 14.
Artigo
Inglês
| MEDLINE | ID: mdl-35093212
18.
Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CT.
Oncotarget
; 8(49): 85110-85119, 2017 Oct 17.
Artigo
Inglês
| MEDLINE | ID: mdl-29156707
19.
Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study.
Oncotarget
; 7(51): 85573-85583, 2016 Dec 20.
Artigo
Inglês
| MEDLINE | ID: mdl-27458168
20.
Clinical impact of contrast-enhanced computed tomography combined with low-dose (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management.
Leuk Lymphoma
; 55(12): 2887-92, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24597987